Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 12 June, 2018

Competition and Mkts

Merger Update

RNS Number : 1813R
Competition and Markets Authority
12 June 2018
 

 

 

 

 

COMPLETED ACQUISITION BY MENZIES AVIATION (UK) LIMITED OF PART OF THE BUSINESS OF AIRLINE SERVICES LIMITED

Invitation to comment

The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

To assist it with this assessment, the CMA invites comments on the transaction from any interested party. These comments should be provided by the deadline set out below to:

Case officer name: Francisca Mendia-Lara

Tel no: 0203 738 6159

E-mail: [email protected]

Affected sector: Aerospace

Case number: ME/6746/18

Expected Decision Date: 7 August 2018

Deadline for comments: 26 June 2018.

Your name and contact details are your personal data.  In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MERSFSFMEFASELM

a d v e r t i s e m e n t